Cooley M&A

DECEMBER 14, 2020

A SPAC, or “blank check company,” is a corporate vehicle created for the sole purpose of acquiring an existing private company and taking it public within a specified time frame. According to Odeon Capital Group research, as of December 2, 2020, 210 SPAC IPOs had been completed representing gross proceeds of ~$72 billion.

IPO 52

IPO Mergers and Acquisitions Investors Private Equity 52

The TRADE

JANUARY 16, 2024

The new firm – Panmure Liberum – will be a market maker in over 750 stocks with all-cap execution capabilities and have over 250 quoted corporate clients with market cap of £250 million. Together the two firms have an aggregate of £9.9

Investment Banking 111

Investment Banking Mergers Bank Banking 111

Razorpay

AUGUST 9, 2023

Huge corporations have investment banks. Portfolio Management Merchant banking companies provide portfolio management services to high -net-worth individuals and corporate investors. Loan Syndication Merchant bankers help arrange funds for large corporate borrowers by syndicating loans from multiple lenders.

Bank 52

Bank Banking Business Underwriting 52

Focus Investment Banking

APRIL 14, 2024

Jim Sowers is a Managing Director with more than 30 years of experience in investment banking and corporate finance. Jim has worked on numerous IPOs, sell-side transactions, fairness opinions, and capital raises, mainly for consumer products companies and restaurants.

M&A 52

M&A Food Private Equity Manufacturing 52

Mergers and Inquisitions

MAY 24, 2023

Event-Driven Hedge Funds Definition: Event-driven hedge funds bet on specific corporate actions, such as M&A deals, divestitures, spin-offs, bankruptcies, and business reorganizations, and they profit based on changes in the value of a company’s debt or equity after the action. revenue and 11.5x EBITDA multiple , matching its own.

Funds 64

Funds Investors Mergers and Acquisitions Mergers 64

Mergers and Inquisitions

MARCH 5, 2025

In technology, as a startup keeps raising capital, it normally does so at gradually higher valuations as its customers, users, and revenue grow. But in biotech, companies valuations often remain close to their total capital raised until much later in the process (i.e.,

Funds 64

Funds Healthcare Mergers and Acquisitions Valuation 64